To include your compound in the COVID-19 Resource Center, submit it here.

Therapeutics: OX40 ligand (OX40L; CD134L)

Autoimmune disease

INDICATION: Scleroderma

Patient sample and mouse studies suggest inhibiting OX40L could help treat systemic sclerosis. In patient skin and serum samples,

Read the full 219 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE